By
Drug Target Review2025-11-25T08:43:22
Scientists have discovered that the drug Rhosin can rejuvenate ageing blood stem cells by inhibiting a key protein linked to cellular decline, providing a potential new strategy to combat age-related diseases.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-09-27T13:56:39
Sponsored by Euretos
2026-05-26T09:05:00
Contributor Thomas Clozel M.D., By Drug Target Review
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2024-03-08T10:00:25
Sponsored by Molecular Devices
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2023-05-18T10:39:07
Sponsored by BPS Bioscience
Site powered by Webvision Cloud